4 results
Article
United States: Pharmaceutical Antitrust 2025
Alert
DOJ Antitrust Division Announces Deferred Prosecution Agreements with Two Pharmaceutical Companies Containing “Extraordinary” Divestiture Remedy
Article
United States: Pharmaceutical Antitrust 2024
Article
Third Circuit: Pharmaceutical Cases